Patent Update Cardiovascular & Renal: Advances in antihypertensive agents
- 1 May 1994
- journal article
- Published by Informa Healthcare in Expert Opinion on Therapeutic Patents
- Vol. 4 (5) , 505-524
- https://doi.org/10.1517/13543776.4.5.505
Abstract
(1994). Patent Update Cardiovascular & Renal: Advances in antihypertensive agents. Expert Opinion on Therapeutic Patents: Vol. 4, No. 5, pp. 505-524. doi: 10.1517/13543776.4.5.505Keywords
This publication has 12 references indexed in Scilit:
- Substituted piperidin-2-one biphenyltetrazoles as angiotensin II antagonistsBioorganic & Medicinal Chemistry Letters, 1992
- Discovery of a novel class of orally active, non-peptide angiotensin II antagonistsJournal of Medicinal Chemistry, 1992
- C-linked pyrazole biaryl tetrazoles as antagonists of angiotensin IIBioorganic & Medicinal Chemistry Letters, 1992
- The Calcium Channel Blocker LAS 30538, Unlike Nifedipine, Verapamil, Diltiazem or Flunarizine, Potently Inhibits Insulin Secretion In-vivo in Rats and DogsJournal of Pharmacy and Pharmacology, 1992
- Cardiovascular Effects of LAS 30538, a New Vascular Selective Ca2+-Channel BlockerJournal of Pharmacy and Pharmacology, 1992
- (R)-2-(3-mercapto-2(S)-methyl-1-oxopropoxy)-3-(methylthio)propanoic acid (FPL 66564), the first ultra-short-acting angiotensin converting enzyme inhibitorJournal of Medicinal Chemistry, 1992
- OPC-13340, a New Dihydropyridine Calcium Channel Blocker Attenuates Rapid Vascular Smooth Muscle Cell Growth in Spontaneously Hypertensive RatsJournal of Cardiovascular Pharmacology, 1992
- Design of a functional hexapeptide antagonist of endothelinJournal of Medicinal Chemistry, 1992
- The endothelin receptor antagonist, BQ-123, inhibits angiotensin II-induced contractions in rabbit aortaBiochemical and Biophysical Research Communications, 1992
- Antihypertensive Effects of MPC-1304, a Novel Calcium Antagonist, in Experimental Hypertensive Rats and DogsJournal of Cardiovascular Pharmacology, 1992